Home Newsfeeds Apple Issues New App Store Rules for Crypto and NFT Payments

Apple Issues New App Store Rules for Crypto and NFT Payments

-Bloomberg https://www.bloomberg.com/news/articles/2022-10-25/apple-issues-new-app-store-rules-for-crypto-and-nft-payments

byCharles Gross

October 25, 2022

1 minute read

-Bloomberg

https://www.bloomberg.com/news/articles/2022-10-25/apple-issues-new-app-store-rules-for-crypto-and-nft-payments

BMO Capital Maintains Market Perform on Royal Gold, Lowers Price Target to $140

By Benzinga Newsdesk

August 4, 1:33 PM

BMO Capital analyst Jackie Przybylowski maintains Royal Gold (NASDAQ:RGLD) with a Market Perform and lowers the price target from $142 to $140.

RGLD

IPOs
News

Golden Heaven Group Holdings Ltd. Announces Pricing Of Initial Public Offering Of 1.75M Shares At A Price Of $4/Share; Expected To Begin Trading On The Nasdaq Capital Market On April 12, 2023 Under The Symbol “GDHG”

By Happy Mohamed

April 12, 11:12 AM

Golden Heaven Group Holdings Ltd. (the "Company" or "Golden Heaven"), an amusement park operator in China, has announced today the pricing of its initial public offering (the "Offering") of

GDHG

On Oct 3, 2022, Avidity Biosciences Announced Its Planned Fortitude Trial Of AOC 1020 In Adult Participants With Facioscapulohumeral Muscular Dystrophy

By Benzinga Newsdesk

October 4, 4:13 PM

- Reuters

RNA

MicroStrategy Ups Convertible Note Offering To $700M To Fuel Bitcoin Acquisitions

By Murtuza Merchant

June 14, 11:37 AM

MicroStrategy increases convertible notes offering to $700 million, with an interest rate of 2.25% per annum, to acquire more Bitcoin and support corporate growth.

MSTR

Apple Issues New App Store Rules for Crypto and NFT Payments

Related Posts

BMO Capital Maintains Market Perform on Royal Gold, Lowers Price Target to $140

Golden Heaven Group Holdings Ltd. Announces Pricing Of Initial Public Offering Of 1.75M Shares At A Price Of $4/Share; Expected To Begin Trading On The Nasdaq Capital Market On April 12, 2023 Under The Symbol “GDHG”

On Oct 3, 2022, Avidity Biosciences Announced Its Planned Fortitude Trial Of AOC 1020 In Adult Participants With Facioscapulohumeral Muscular Dystrophy

MicroStrategy Ups Convertible Note Offering To $700M To Fuel Bitcoin Acquisitions